Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer

Galanin receptors as a potential target for neurological disease

(2015) Krista Freimann et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Involvements of galanin and its receptors in antinociception in nucleus accumbens of rats with inflammatory pain

(2015) Yang Yang et al.   NEUROSCIENCE RESEARCH

Galanin Has Tumor Suppressor Activity and Is Frequently Inactivated by Aberrant Promoter Methylation in Head and Neck Cancer

(2014) Kiyoshi Misawa et al.   Translational Oncology

Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer

(2013) Yuki Misawa et al.   CANCER

GALR1 Methylation in Vaginal Swabs Is Highly Accurate in Identifying Women With Endometrial Cancer

(2013) Konstantinos Doufekas et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Exogenous galanin attenuates spatial memory impairment and decreases hippocampal beta-amyloid levels in rat model of Alzheimer's disease

(2013) Lei Li et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas

(2013) Efterpi Kostareli et al.   JOURNAL OF CLINICAL INVESTIGATION

Comprehensive Analysis of DNA Methylation in Head and Neck Squamous Cell Carcinoma Indicates Differences by Survival and Clinicopathologic Characteristics

(2013) Justin A. Colacino et al.   PLoS One

Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer

(2012) L. Stevenson et al.   CLINICAL CANCER RESEARCH

Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study

(2012) Grant D. Stewart et al.   JOURNAL OF UROLOGY

Ligand binding properties of human galanin receptors

(2012) Wiktor Jurkowski et al.   MOLECULAR MEMBRANE BIOLOGY

Molecular Evolution of a Peptide GPCR Ligand Driven by Artificial Neural Networks

(2012) Sebastian Bandholtz et al.   PLoS One

Detection of Promoter Hypermethylation in Salivary Rinses as a Biomarker for Head and Neck Squamous Cell Carcinoma Surveillance

(2011) A. L. Carvalho et al.   CLINICAL CANCER RESEARCH

Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers

(2011) Jin C. Kim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cancer epigenetics reaches mainstream oncology

(2011) Manuel Rodríguez-Paredes et al.   NATURE MEDICINE

Cancer Epigenetics

(2010) Rodolphe Taby et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma

(2010) Takeharu Kanazawa et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

G protein-coupled receptors: novel targets for drug discovery in cancer

(2010) Rosamaria Lappano et al.   NATURE REVIEWS DRUG DISCOVERY

Galanin Receptor Subtype 2 Suppresses Cell Proliferation and Induces Apoptosis in p53 Mutant Head and Neck Cancer Cells

(2009) T. Kanazawa et al.   CLINICAL CANCER RESEARCH

Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer

(2008) K. Misawa et al.   CLINICAL CANCER RESEARCH

DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer

(2008) Malcolm V. Brock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2)

(2008) R. Tofighi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA